# Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1

> **NCT02944032** · NA · COMPLETED · sponsor: **Kristina Hardy** · enrollment: 103 (actual)

## Conditions studied

- Neurofibromatosis Type 1

## Interventions

- **OTHER:** CogmedRM
- **OTHER:** Mobymax

## Key facts

- **NCT ID:** NCT02944032
- **Lead sponsor:** Kristina Hardy
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-05
- **Primary completion:** 2021-09-27
- **Final completion:** 2021-09-27
- **Target enrollment:** 103 (ACTUAL)
- **Last updated:** 2022-03-03

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02944032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02944032, "Efficacy of Computerized Cognitive Training and Stimulant Medication in Neurofibromatosis Type 1". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02944032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*